231 related articles for article (PubMed ID: 8993844)
1. Transgenic rats: tools to study the function of the renin-angiotensin system.
Bader M; Ganten D
Clin Exp Pharmacol Physiol Suppl; 1996; 3():S81-7. PubMed ID: 8993844
[TBL] [Abstract][Full Text] [Related]
2. Transgenic rats: tools to study the function of the renin-angiotensin system.
Bader M; Ganten D
Clin Exp Pharmacol Physiol; 1996 Sep; 23 Suppl 3():S81-7. PubMed ID: 21143278
[TBL] [Abstract][Full Text] [Related]
3. Reversal of the suppressed kidney renin level in the hypertensive transgenic rat TGR(mRen-2)27 by angiotensin converting enzyme inhibition.
Tokita Y; Franco-Saenz R; Mulrow PJ
Am J Hypertens; 1995 Oct; 8(10 Pt 1):1031-9. PubMed ID: 8845072
[TBL] [Abstract][Full Text] [Related]
4. Increased adrenal renin in transgenic hypertensive rats, TGR(mREN2)27, and its regulation by cAMP, angiotensin II, and calcium.
Peters J; Münter K; Bader M; Hackenthal E; Mullins JJ; Ganten D
J Clin Invest; 1993 Mar; 91(3):742-7. PubMed ID: 8383701
[TBL] [Abstract][Full Text] [Related]
5. Adrenal renin expression and its role in ren-2 transgenic rats TGR(mREN2)27.
Peters J; Ganten D
Horm Metab Res; 1998; 30(6-7):350-4. PubMed ID: 9694562
[TBL] [Abstract][Full Text] [Related]
6. The renin-angiotensin system and renal function in transgenic (mRen2)27 rats.
Gross V; Lippoldt A; Bohlender J; Ganten D; Ganten U; Luft FC
Exp Nephrol; 1996; 4 Suppl 1():20-6. PubMed ID: 9001893
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of aortic and cardiac AT1 receptor gene expression in transgenic (mRen-2) 27 rats.
Nickenig G; Laufs U; Schnabel P; Knorr A; Paul M; Böhm MP
Br J Pharmacol; 1997 May; 121(1):134-40. PubMed ID: 9146897
[TBL] [Abstract][Full Text] [Related]
8. [A comparative study of cardiac function in transgenic hypertensive rats, in spontaneously hypertensive rats and in normotensive rats].
Bohlender J; Hildenbrand U; Schlegel WP; Hempel P; Nissen E; Krause EG; Bartel S
Arch Mal Coeur Vaiss; 2000 Aug; 93(8):993-6. PubMed ID: 10989744
[TBL] [Abstract][Full Text] [Related]
9. Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene.
Mullins JJ; Peters J; Ganten D
Nature; 1990 Apr; 344(6266):541-4. PubMed ID: 2181319
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II receptor blockade in TGR(mREN2)27: effects of renin-angiotensin-system gene expression and cardiovascular functions.
Böhm M; Lee M; Kreutz R; Kim S; Schinke M; Djavidani B; Wagner J; Kaling M; Wienen W; Bader M
J Hypertens; 1995 Aug; 13(8):891-9. PubMed ID: 8557967
[TBL] [Abstract][Full Text] [Related]
11. [Development of a model of human renin hypertension in rats].
Bohlender J; Ménard J; Wagner J; Luft FC; Ganten D
Arch Mal Coeur Vaiss; 1996 Aug; 89(8):1009-11. PubMed ID: 8949369
[TBL] [Abstract][Full Text] [Related]
12. Genetics of primary hypertension.
Ganten D; Schmidt S; Paul M
J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S45-50. PubMed ID: 7700065
[TBL] [Abstract][Full Text] [Related]
13. Genetic clamping of renin gene expression induces hypertension and elevation of intrarenal Ang II levels of graded severity in Cyp1a1-Ren2 transgenic rats.
Mitchell KD; Bagatell SJ; Miller CS; Mouton CR; Seth DM; Mullins JJ
J Renin Angiotensin Aldosterone Syst; 2006 Jun; 7(2):74-86. PubMed ID: 17083061
[TBL] [Abstract][Full Text] [Related]
14. Low-dose renin inhibitor and low-dose AT(1)-receptor blocker therapy ameliorate target-organ damage in rats harbouring human renin and angiotensinogen genes.
Dechend R; Shagdarsuren E; Gratze P; Fiebeler A; Pilz B; Meiners S; Derer W; Feldman DL; Webb R; Muller DN
J Renin Angiotensin Aldosterone Syst; 2007 Jun; 8(2):81-4. PubMed ID: 17703434
[TBL] [Abstract][Full Text] [Related]
15. Changes in endothelium-derived hyperpolarizing factor in hypertension and ageing: response to chronic treatment with renin-angiotensin system inhibitors.
Goto K; Fujii K; Kansui Y; Iida M
Clin Exp Pharmacol Physiol; 2004 Sep; 31(9):650-5. PubMed ID: 15479174
[TBL] [Abstract][Full Text] [Related]
16. Dependence of angiotensin production in transgenic mice carrying either the human renin or human angiotensinogen genes on species-specific kinetics of the renin-angiotensin system.
Fukamizu A; Takimoto E; Sugimura K; Hatae T; Seo MS; Takahashi S; Sugiyama F; Kajiwara N; Yagami K; Murakami K
Arzneimittelforschung; 1993 Feb; 43(2A):222-5. PubMed ID: 8498968
[TBL] [Abstract][Full Text] [Related]
17. Long-term blockade of the angiotensin II receptor in renin transgenic rats, salt-loaded Dahl rats, and stroke-prone spontaneously hypertensive rats.
Stasch JP; Knorr A; Hirth-Dietrich C; Krämer T; Hübsch W; Dressel J; Fey P; Beuck M; Sander E; Frobel K; Kazda S
Arzneimittelforschung; 1997 Sep; 47(9):1016-23. PubMed ID: 9342414
[TBL] [Abstract][Full Text] [Related]
18. Behaviour of the transgenic (mREN2)27 rat.
Wilson W; Voigt P; Bader M; Marsden CA; Fink H
Brain Res; 1996 Aug; 729(1):1-9. PubMed ID: 8874871
[TBL] [Abstract][Full Text] [Related]
19. Species specificity of renin kinetics in transgenic rats harboring the human renin and angiotensinogen genes.
Ganten D; Wagner J; Zeh K; Bader M; Michel JB; Paul M; Zimmermann F; Ruf P; Hilgenfeldt U; Ganten U
Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7806-10. PubMed ID: 1502199
[TBL] [Abstract][Full Text] [Related]
20. Targeting mechanisms of hypertensive vascular disease with dual calcium channel and renin-angiotensin system blockade.
Weir MR
J Hum Hypertens; 2007 Oct; 21(10):770-9. PubMed ID: 17597800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
